ISWH Issues Q4 Roadmap and Operational Update: All Core Segments Set for Simultaneous Revenue Growth

LAS VEGAS, Sept. 25, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — International Spirits & Wellness Holdings, Inc. (OTCMKTS: ISWH) (“ISWH” or the “Company”), a top-tier brand incubator in the Spirits, CBD-Infused Products, and Home Healthcare markets, is excited to issue a Corporate Update on the Company’s strategic roadmap for operations and revenue-generating activity in the final quarter of 2019. The Company anticipates a strong quarter in Q4 2019, representing the first quarter in Company history when all three of its core segments are set for simultaneous revenue growth.

P19 CBD-based Product Sales. As noted in the Company’s release dated September 17, 2019, sales of its P19 branded CBD-based product line are set to resume this month. The Company believes that overall growth in the CBD space, as well as its strengthened position with its key strategic manufacturing, marketing, and distribution partner, BioPulse Labs (“BioPulse”), will create increased potential for outsized upside performance for the P19 segment in Q4 2019.

The Company will begin actively marketing its nano-Infused CBD products, including P19 CBD Tinctures, P19 vegan CBD Gummies, P19 CBD Pain Cream, P19 Nano Nectar CBD Drops, and P19 Flavored CBD Shooters.

Home Healthcare. Home health spending is expected increase at a faster rate through 2027 than all other categories of healthcare, according to a recent analysis from the Centers for Medicare & Medicaid Services (CMS) Office of the Actuary. Home health care spending is expected to reach more than $186 billion in 2027, according to the report.

The Company has targeted significant growth in the space over coming quarters, ramping investment as market returns continue to validate the thesis. Thus far, this strategy has been extremely productive, driving 6,400% sequential quarterly revenue growth in Q2 2019 (quarter-ended June 30). Management maintains its forecast for the segment to contribute significantly to the Company’s first-ever profitable fiscal quarter (on an EBITDA basis) in Q3 2019 (quarter-ended September 30).

Spirits. Management notes that it has set in motion the process of a strong year-end production and distribution run for its award-winning Besado Tequila brand. October, November, and December, taken as a unit, represent over 40 percent in total annual sales for the spirits industry. Given that this represents just 25 percent of the calendar year, this is a powerful seasonal factor.

As such, the Company has limited its investment in this segment in recent months as part of a strategy to emphasize new Besado production and distribution footprint expansion when it coincides with this seasonally advantageous period. Expanded distribution of Besado is set to begin next month.

Terry Williams, ISWH CEO, commented, “We are set to enter Q4 with all cylinders firing. Our CBD-based products segment will be back logging sales at a time when that market is experiencing unprecedented growth. Our home healthcare segment, which has been a stalwart performer, will be emphasized further, driving growth and profitability. And our Besado brand will enter its seasonally strongest period. We have turned a significant corner this year, and Q4 2019 should serve as a demonstration of that progress.”

About ISWH: International Spirits & Wellness Holdings, Inc. (ISWH) is an authorized importer, licensor, and marketer of premium beverage brands, with sales of innovative products and brands worldwide. Based in Nevada, the Company’s expertise lies in the strategic development and aggressive early growth of its brands and the establishment of these brands as viable and profitable as an incubator. ISWH intends to nurture emerging brands through critical stages of market development, including conceptualization, go-to-market strategy, supply chain and logistics engineering, integrated marketing, and distribution. In addition, ISWH has now established itself as a health and wellness company with a focus on reshaping the CBD products market through state-of-the-art nanotechnology processes, developing a wide range of nano-infused CBD gummies and beverages formulations. These products will be sold through the Company’s website, as well as through established wholesale and retail distribution channels. The company has also partnered with Bengala Technologies to develop and commercialize enterprise and B2B software technology products targeting the logistics and supply-chain marketplace.

Forward Looking Statements: This press release may contain forward-looking statements that involve risks and uncertainties. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology including “could”, “may”, “will”, “should”, “expect”, “plan”, “anticipate”, “believe”, “estimate”, “predict”, “potential” and the negative of these terms or other comparable terminology. While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggested in this report. Except as required by applicable law, we do not intend to update any of the forward-looking statements so as to conform these statements to actual results. Investors should refer to the risks disclosed in the Company’s reports filed from time to time with OTC Markets (www.otcmarkets.com).

Contact:
For Additional Investor Information:
International Spirits & Wellness Holdings, Inc.
info@isbg.global

ISWH Set to Resume Full-Scale CBD-based Product Sales as CBD Market Surges to $5B in 2019

LAS VEGAS, Sept. 17, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — International Spirits & Wellness Holdings, Inc. (OTCMKTS: ISWH) (“ISWH” or the “Company”), a top-tier brand incubator in the Spirits, CBD-Infused Products, and Home Healthcare markets, is pleased to announce that sales of its hemp-derived CBD products are set to resume. Marketing and distribution will be coordinated through its strategic partner, BioPulse Labs (“BioPulse”), a market leader in CBD nano-infusion technology and ecommerce marketing and distribution.

“Growth estimates for the overall CBD market are in the process of being revised sharply higher as mainstream consumer adoption dramatically outperforms prior baseline expectations for 2019,” commented Terry Williams, ISWH CEO. “It’s a perfect time for our diverse array of hemp-derived CBD products to resume live sales and distribution. This is a principle reason we have had to mark up our financial expectations heading into Q4.”

The Company will be marketing P19 Nano-Infused CBD Tinctures, P19 vegan CBD Gummies, P19 CBD Pain Cream, P19 Nano Nectar CBD Drops, and P19 Flavored CBD Shooters. All products are nano-infused with CBD derived from hemp, which is fully legal in all 50 states. Nano-infusion ensures the highest possible bioavailability, which is particularly important given the powerful health and wellness applications for cannabidiol (CBD).

Management notes that the Company is eager to restart sales given recent upward adjustments to forecasts for growth in CBD demand over coming quarters. Brightfield Group, a leading market and consumer intelligence firm for the legal CBD and cannabis industries, recently increased its own growth forecast for the CBD market, published analysis calling for a 706% year-over-year CBD product sales jump in the US in 2019 to around $5 billion in total sales, with sales expected to reach $23.7 billion by 2023.

“This is a rare marketplace,” continued Mr. Williams. “New research calls for a CAGR in the CBD-based products space of 107% for the next 4 years. That’s just staggering. I’m not sure I’ve ever seen anything like it. This whole marketplace is being sucked up into a massive black hole of demand as CBD finally really hits the radar of the mainstream public. We have inventory and branding already in place for a market-leading product line, and we have marketing and distribution ready to come back online into quarter end. That puts the Company in an especially advantageous position right now.”

About ISWH: International Spirits & Wellness Holdings, Inc. (ISWH) is an authorized importer, licensor, and marketer of premium beverage brands, with sales of innovative products and brands worldwide. Based in Nevada, the Company’s expertise lies in the strategic development and aggressive early growth of its brands and the establishment of these brands as viable and profitable as an incubator. ISWH intends to nurture emerging brands through critical stages of market development, including conceptualization, go-to-market strategy, supply chain and logistics engineering, integrated marketing, and distribution. In addition, ISWH has now established itself as a health and wellness company with a focus on reshaping the CBD products market through state-of-the-art nanotechnology processes, developing a wide range of nano-infused CBD gummies and beverages formulations. These products will be sold through the Company’s website, as well as through established wholesale and retail distribution channels. The company has also partnered with Bengala Technologies to develop and commercialize enterprise and B2B software technology products targeting the logistics and supply-chain marketplace.

Forward Looking Statements: This press release may contain forward-looking statements that involve risks and uncertainties. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology including “could”, “may”, “will”, “should”, “expect”, “plan”, “anticipate”, “believe”, “estimate”, “predict”, “potential” and the negative of these terms or other comparable terminology. While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggested in this report. Except as required by applicable law, we do not intend to update any of the forward-looking statements so as to conform these statements to actual results. Investors should refer to the risks disclosed in the Company’s reports filed from time to time with OTC Markets (www.otcmarkets.com).

Contact:
For Additional Investor Information:
International Spirits & Wellness Holdings, Inc.
info@isbg.global

ISWH to Turn Profitable on EBITDA Basis in Q3 2019, Revenue Growth to Accelerate

LAS VEGAS, Sept. 10, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — International Spirits & Wellness Holdings, Inc. (OTCMKTS: ISWH) (“ISWH” or the “Company”), a top-tier brand incubator in the Spirits, CBD-Infused Products, and Home Healthcare markets, is very excited to announce that it is on track to post its first ever quarter of profitability on an EBITDA (earnings before interest, tax, depreciation and amortization) basis in the Company’s fiscal third quarter (ending September 30, 2019).

The Company also now expects both nominal revenues and quarterly year/year revenue growth rate will supersede the strong top-line results filed by the Company for its Q2 quarter ended June 30, 2019. In addition, the Company will be filing fully-audited financial results at year-end. At this point, the Company is on pace for record results in 2019 in terms of financial performance, and management anticipates applying to uplist onto the OTCQB exchange tier in coming months.

“Our home healthcare segment has been driving recent growth during our marketing and distribution transition for our CBD product line and ahead of our planned distribution expansion for Besado Tequila in October,” noted Terry Williams, ISWH CEO. “In other words, this is a three engine plane that has basically been flying on one engine over recent months. But that’s all about to change. Q3 is the turning point. Q4 is going to be the real story.”

Management notes that the Company is set to shortly resume online sales of its P19 premium quality hemp-derived line of branded CBD-based health and wellness products. The Company anticipates sales of CBD-based products to contribute to Q3 results and significantly drive Q4 growth.

In addition, the Company is setting up to sharply expand its distribution footprint for its award-winning Besado Tequila brand, and will release further details on this expanded spirits strategy in coming communications.

“We have been planning our second-half strategy carefully with the idea that we will really be able to turn on the juice from right now through the end of the year,” continued Mr. Williams. “We put out an update back in January claiming that 2019 was going to be the year that we really turned the corner. We are very gratified to be able to sit here now in September and confirm that thesis based on empirical data.”

About ISWH: International Spirits & Wellness Holdings, Inc. (ISWH) is an authorized importer, licensor, and marketer of premium beverage brands, with sales of innovative products and brands worldwide. Based in Nevada, the Company’s expertise lies in the strategic development and aggressive early growth of its brands and the establishment of these brands as viable and profitable as an incubator. ISWH intends to nurture emerging brands through critical stages of market development, including conceptualization, go-to-market strategy, supply chain and logistics engineering, integrated marketing, and distribution. In addition, ISWH has now established itself as a health and wellness company with a focus on reshaping the CBD products market through state-of-the-art nanotechnology processes, developing a wide range of nano-infused CBD gummies and beverages formulations. These products will be sold through the Company’s website, as well as through established wholesale and retail distribution channels. The company has also partnered with Bengala Technologies to develop and commercialize enterprise and B2B software technology products targeting the logistics and supply-chain marketplace.

Forward Looking Statements: This press release may contain forward-looking statements that involve risks and uncertainties. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology including “could”, “may”, “will”, “should”, “expect”, “plan”, “anticipate”, “believe”, “estimate”, “predict”, “potential” and the negative of these terms or other comparable terminology. While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggested in this report. Except as required by applicable law, we do not intend to update any of the forward-looking statements so as to conform these statements to actual results. Investors should refer to the risks disclosed in the Company’s reports filed from time to time with OTC Markets (www.otcmarkets.com).

Contact:
For Additional Investor Information:
International Spirits & Wellness Holdings, Inc.
info@isbg.global